Featured patents

Substituted Benzamide Derivatives as Glucokinase (GK) Activators
US 08835469 B2, Sept. 16, 2014, Plural ring chalcogens in the hetero ring, Rajendra Kharul et al. / Cadila Healthcare Limited (Gujarat, IN)
Compounds having the structure of Formula (I),…

Substituted 4-Hydroxypyrimidine-5-Carboxamides
US 08815865 B2, Aug. 26, 2014, The additional hetero ring is a diazine, Matthew J. Clements et al. / Merck Sharp & Dohme Corp. (Rahway, US)
A compound selected from the group consisting of:…

1,4-Oxazepines as BACE1 And/Or BACE2 Inhibitors
US 08815841 B2, Aug. 26, 2014, Additional nitrogen containing hetero ring attached directly or indirectly to the seven-membered hetero ring by nonionic bonding, Hans Hilpert et al. / Hoffmann-La Roche Inc. (Nutley, US)
A compound of the formula I:…

N-(Imidazolidin-2-Ylidene)quinoline Derivatives as Modulators of Alpha 2 Adrenergic Receptors
US 08815861 B2, Aug. 26, 2014, 1,4-diazine as one of the cyclos, Michael E. Garst et al. / Allergan, Inc. (Irvine, US)
A compound of Formula I, an enantiomer, a diastereoisomer, a tautomer…

Naphthoquinones for Disease Therapies
US 08871802 B2, Oct. 28, 2014, Polycyclo ring system having the hetero ring as one of the cyclos, Jiali Xu et al. / Zhoushan HaiZhongZhou Xinsheng Pharmaceuticals Co., Ltd. (Zhoushan, CN)
A compound of formula I:…

Specific HCV NS3 Protease Inhibitors
US 08729014 B2, May 20, 2014, Hepatitis, Philippe Halfon et al. / RFS Pharma, LLC (Tucker, US)
A compound of Formula (I):…

GLP-1 Analogues and Their Pharmaceutical Salts and Uses
US 08614182 B2, Dec. 24, 2013, Glucagon, glucagon-like peptide or derivative affecting or utilizing, Hengli Yuan et al. / Jiangsu Hansoh Pharmaceuticals Co., Ltd. (Lianyungang, Jiangsu, CN)
A GLP-1 analogue or a pharmaceutically acceptable salt thereof comprising:…

Nitrogen-Containing Six-Membered Aromatic Ring Derivatives and Pharmaceutical Products Containing the Same
US 08592435 B2, Nov. 26, 2013, Pyrimidines with chalcogen bonded directly to a ring carbon of said pyrimidine moiety, Chikaomi Yamada et al. / Daiichi Sankyo Company, Limited (Tokyo, JP)
A compound, wherein the compound is:…

Modified Galectin 9 Proteins and Methods of Treatment Using Them
US 08580743 B2, Nov. 12, 2013, Anti-inflammatory, Akira Yamauchi et al. / Galpharma Co., Ltd. (Kagawa, JP)
A pharmaceutical drug comprising:…

Juvenile Hemochromatosis Gene (HFE2A) Cleavage Products and Uses Thereof
US 08507435 B2, Aug. 13, 2013, Blood affecting or blood protein utilizing, Yigal Goldberg et al. / Xenon Pharmaceuticals, Inc. (Burnaby, B.C., CA)
A method for treating a disease of iron metabolism comprising administering…

Patentorg has 8391 documents under Drugs: Designated Organic Active Ingredient Containing Patents.

Narrow down the browsing criteria below to see more patents.

Select a subcategory
Quick navigation
New documents
  • Process for the Production of the Actinobacillus Pleuropneumoniae Toxins APXI or APXIII in a Liquid Culture Medium Under Supply of Air Enriched in Carbon Dioxide
  • Method for Manufacturing Nonvolatile Memory Device
  • Supply Chain Demand Satisfaction
  • Supply-Line Management Device
  • Storage Control Device and Method for Managing Snapshot